CDNA vs WGS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

CDNA

32.9
AI Score
VS
WGS Wins

WGS

54.6
AI Score

Investment Advisor Scores

CDNA

33score
Recommendation
SELL

WGS

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CDNA WGS Winner
Revenue 249.65M 216.69M CDNA
Net Income 113.44M -81.06M CDNA
Net Margin 45.4% -37.4% CDNA
Operating Income 114.42M -74.93M CDNA
ROE 26.7% -33.2% CDNA
ROA 21.3% -16.8% CDNA
Total Assets 532.99M 481.49M CDNA
Cash 373.64M 60.32M CDNA
Current Ratio 4.58 3.30 CDNA
Free Cash Flow 29.26M -77.96M CDNA

Relative Price Performance (Last 90 Days)

CDNA 1M: +36.1% · 3M: +128.3% WGS 1M: -14.8% · 3M: +7.1%

Current Technical Phase

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81

RSI (14): 80.8 · Price: $66.66

WGS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.2 · Price: $72.30

Fundamentals Snapshot

Metric CDNA WGS
Market Cap — —
Forward P/E 51.3 59.2
Trailing P/E 30.8 —
Revenue (TTM) — —
Revenue Growth 0.5% 0.1%
Gross Margin 0.7% 0.7%
Operating Margin 0.0% -0.2%
EPS 2.11 -3.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, WGS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.